Re: Castration trial outcome poll
u/drwillpowers
r/DrWillPowers2026-10-02T17:09:19Z
Dr Will Powers’ own statements and theorizing
Mentions treatments or doses — not guidance
Summary (paraphrased)
Powers gave what he called an honest take on the castration trials: temporary chemical castration improves androgenic signaling for patients with androgenic signal loss, but does nearly nothing for brain symptoms such as low libido or anhedonia. He said the team is investigating why this split occurs and whether the GABA-A PAM neurosteroid load is affected at all, and that answering it requires CSF taps with mass spectrometry — noting he had met with a research team the prior week to discuss doing it in-house versus finding a site for patients. He described treating suspected neurosteroid-excess cases with various agents, some producing drastic reactions, and characterized correcting the underlying anomaly as a delicate, prolonged process because the brain has been bathed in GABA-A PAMs for so long. He added that the PSSD link was recently discovered through elevated androsterone blood labs even in female patients, and that the ideal targeting approach remains unknown — discovered by trial and error.
Key points (paraphrased)
- Castration reportedly helps peripheral/androgenic symptoms (muscle loss etc.) but not psychological ones (libido, anhedonia).
- Open question: whether castration alters the central GABA-A PAM neurosteroid load at all.
- CSF taps + mass spectrometry identified as the needed next step; discussed with a research team.
- Neurosteroid correction described as delicate and prolonged; some interventions caused drastic reactions.
- PSSD connection via elevated androsterone labs in females noted as a recent discovery.
Why it’s in the corpus
The clearest statement of the castration trial's limitations — it separates the syndrome into a castration-responsive peripheral phenotype and a castration-resistant central phenotype, anchoring the two-subtype model that runs through Powers' 2026 work. Also documents his shift toward CSF-based biomarker research.
Context — the post Powers was replying toVerbatim third-party text, shown for context only — not Powers’ statement. Usernames removed.ShowHide
Powers' comment replies to the original post "Castration trial outcome poll" by [username removed]:
[deleted]
(Parent context recovered from the r.genit.al mirror on 2026-10-07; Powers' comment text itself is from John's user-provided export.)
Some fields on this page come from the release’s Markdown edition, which carries text the JSON edition omits.
Related records
- Powers · Reddit commentCurated Powers pick
Re: Theory as to why some people so sensitive to Calcium-D-Glucarate
u/drwillpowers · r/DrWillPowers
Powers reported that relugolix (temporary chemical castration) at least temporarily fully restores normal androgenic signaling, with patients typically noticing improvement within days — return of acne, body odor, and related signs — persisting for weeks…
PRH-00512026-09-27T16:23:12ZPFSPSSDPowers Reddit history - Powers · Reddit commentCurated Powers pick
Re: Is progesterone therapy still used for some PFS patients?
u/drwillpowers · r/DrWillPowers
Powers said his progesterone/pregnenolone use is now phenotype-specific: he reserves it for patients with an apparent low-neurosteroid-production picture — chronic anxiety, tremors, paranoia, signs of the GABA system being disrupted in the negative direction…
PRH-00072026-10-05T18:43:55ZPFSPowers Reddit history - Powers · Reddit post
Untitled long-form research update — new model of PFS/PSSD/post-drug syndromes (Sept 2026)
u/drwillpowers · r/DrWillPowers
Powers revised his model: the anhedonia/low-libido subtype of PFS/PSSD is driven by pathological EXCESS — not deficiency — of neurosteroids such as THDOC and androsterone that positively modulate GABA-A, causing downstream neural network remodeling…
DWP-0022026PFSPSSDCore corpus